Requisite Role of Kv1.5 Channels in Coronary Metabolic Dilation

Circulation Research

Volumn 117, Issue 7, 2015, Pages 612-621

  Ohanyan, Vahagn ^a   Yin, Liya ^a   Bardakjian, Raffi ^d   Kolz, Christopher ^a   Enrick, Molly ^a   Hakobyan, Tatevik ^a   Kmetz, John ^a   Bratz, Ian ^a   Luli, Jordan ^a   Nagane, Masaki ^c   Khan, Nadeem ^c   Hou, Huagang ^c   Kuppusamy, Periannan ^c   Graham, Jacqueline ^a   Fu, Frances Kwan ^a   Janota, Danielle ^a   Oyewumi, Moses O ^b   Logan, Suzanna ^a   Lindner, Jonathan R ^e   Chilian, William M ^a  

^a Northeastern Ohio Medical University   (United States)

^b NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d Canton Medical Education Foundation   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

cardiac function; contrast echocardiography; hydrogen peroxide; ion channel; transgenic mice; vasodilation; voltage gated potassium channels

Indexed keywords

ACETYLCHOLINE; ADENOSINE; DOXYCYCLINE; NORADRENALIN; POTASSIUM CHANNEL KV1.5;

ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CONTRAST ECHOCARDIOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; CORONARY HEMODYNAMICS; HEART; HEART EJECTION FRACTION; HEART FUNCTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE METABOLISM; HEART RATE; HEART STRESS; HEART WORK; ISOLATED ARTERY; MEAN ARTERIAL PRESSURE; MICROCIRCULATION; MOUSE; NONHUMAN; OXYGEN TENSION; OXYGEN TISSUE LEVEL; PHENOTYPE; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE; 129 MOUSE; ANIMAL; C57BL MOUSE; CORONARY BLOOD VESSEL; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY; TRANSGENIC MOUSE; VASODILATATION;

ANIMALS; CORONARY CIRCULATION; CORONARY VESSELS; KV1.5 POTASSIUM CHANNEL; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MUSCLE, SMOOTH, VASCULAR; VASODILATION;

EID: 84941283159     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.115.306642     Document Type: Article

References (78)

1. Grover RF. Mechanisms augmenting coronary arterial oxygen extraction. Adv Cardiol. 1973;9:89-98.
2. Wolff CB. Normal cardiac output, oxygen delivery and oxygen extraction. Adv Exp Med Biol. 2007;599:169-182.
3. Tennant R, Wiggers CJ. The effect of coronary occlusion on myocardial contraction. Am J Physiol. 1935;112:351. doi: 10.1016/S0002-8703(35)90365-9.
4. Jones CJ, Kuo L, Davis MJ, Chilian WM. Myogenic and flow-dependent control mechanisms in the coronary microcirculation. Basic Res Cardiol. 1993;88:2-10.
5. Jones CJ, Kuo L, Davis MJ, Chilian WM. Regulation of coronary blood flow: coordination of heterogeneous control mechanisms in vascular microdomains. Cardiovasc Res. 1995;29:585-596.
6. Jones CJ, Kuo L, Davis MJ, Chilian WM. Distribution and control of coronary microvascular resistance. Adv Exp Med Biol. 1993;346:181-188.
7. Feigl EO. Coronary physiology. Physiol Rev. 1983;63:1-205.
8. Wu GB, Zhou EX, Qing DX, Li J. Role of potassium channels in regulation of rat coronary arteriole tone. Eur J Pharmacol. 2009;620:57-62. doi: 10.1016/j.ejphar.2009.08.004.
9. Chen TT, Luykenaar KD, Walsh EJ, Walsh MP, Cole WC. Key role of Kv1 channels in vasoregulation. Circ Res. 2006;99:53-60. doi: 10.1161/01. RES.0000229654.45090.57.
10. Knot HJ, Nelson MT. Regulation of membrane potential and diameter by voltage-dependent K+ channels in rabbit myogenic cerebral arteries. Am J Physiol. 1995;269:H348-H355.
11. Lu T, Ye D, Wang X, Seubert JM, Graves JP, Bradbury JA, Zeldin DC, Lee HC. Cardiac and vascular KATP channels in rats are activated by endogenous epoxyeicosatrienoic acids through different mechanisms. J Physiol. 2006;575:627-644. doi: 10.1113/jphysiol.2006.113985.
12. Zatta AJ, Headrick JP. Mediators of coronary reactive hyperaemia in isolated mouse heart. Br J Pharmacol. 2005;144:576-587. doi: 10.1038/sj.bjp.0706099.
13. Dick GM, Tune JD. Role of potassium channels in coronary vasodilation. Exp Biol Med (Maywood). 2010;235:10-22. doi: 10.1258/ebm.2009.009201.
14. Aziz Q, Thomas AM, Gomes J, Ang R, Sones WR, Li Y, Ng KE, Gee L, Tinker A. The ATP-sensitive potassium channel subunit, Kir6.1, in vascular smooth muscle plays a major role in blood pressure control. Hypertension. 2014;64:523-529. doi: 10.1161/HYPERTENSIONAHA.114.03116.
15. Knot HJ, Zimmermann PA, Nelson MT. Extracellular K(+)-induced hyperpolarizations and dilatations of rat coronary and cerebral arteries involve inward rectifier K(+) channels. J Physiol. 1996;492 (Pt 2):419-430.
16. Jackson WF. Potassium channels in the peripheral microcirculation. Microcirculation. 2005;12:113-127. doi: 10.1080/10739680590896072.
17. Rogers PA, Dick GM, Knudson JD, Focardi M, Bratz IN, Swafford AN Jr, Saitoh S, Tune JD, Chilian WM. H2O2-induced redox-sensitive coronary vasodilation is mediated by 4-aminopyridine-sensitive K+ channels. Am J Physiol Heart Circ Physiol. 2006;291:H2473-H2482. doi: 10.1152/ajpheart.00172.2006.
18. Saitoh S, Zhang C, Tune JD, Potter B, Kiyooka T, Rogers PA, Knudson JD, Dick GM, Swafford A, Chilian WM. Hydrogen peroxide: a feed-forward dilator that couples myocardial metabolism to coronary blood flow. Arterioscler Thromb Vasc Biol. 2006;26:2614-2621. doi: 10.1161/01. ATV.0000249408.55796.da.
19. Saitoh S, Kiyooka T, Rocic P, Rogers PA, Zhang C, Swafford A, Dick GM, Viswanathan C, Park Y, Chilian WM. Redox-dependent coronary metabolic dilation. Am J Physiol Heart Circ Physiol. 2007;293:H3720-H3725. doi: 10.1152/ajpheart.00436.2007.
20. Kleppisch T, Nelson MT. ATP-sensitive K+ currents in cerebral arterial smooth muscle: pharmacological and hormonal modulation. Am J Physiol. 1995;269:H1634-H1640.
21. Archer SL, Weir EK, Reeve HL, Michelakis E. Molecular identification of O2 sensors and O2-sensitive potassium channels in the pulmonary circulation. Adv Exp Med Biol. 2000;475:219-240.
22. Archer SL, Wu XC, Thaud B, Nsair A, Bonnet S, Tyrrell B, McMurtry MS, Hashimoto K, Harry G, Michelakis ED. Preferential expression and function of voltage-gated, O2-sensitive K+ channels in resistance pulmonary arteries explains regional heterogeneity in hypoxic pulmonary vasoconstriction: ionic diversity in smooth muscle cells. Circ Res. 2004;95:308-318. doi: 10.1161/01.RES.0000137173.42723.fb.
23. Patel AJ, HonorE. Molecular physiology of oxygen-sensitive potassium channels. Eur Respir J. 2001;18:221-227.
24. Pannasch U, Fber K, Nolte C, Blonski M, Yan Chiu S, Messing A, Kettenmann H. The potassium channels Kv1.5 and Kv1.3 modulate distinct functions of microglia. Mol Cell Neurosci. 2006;33:401-411. doi: 10.1016/j.mcn.2006.08.009.
25. Tiefenbacher CP, DeFily DV, Chilian WM. Requisite role of cardiac myocytes in coronary alpha1-adrenergic constriction. Circulation. 1998;98:9-12.
26. Merkus D, Brzezinska AK, Zhang C, Saito S, Chilian WM. Cardiac myocytes control release of endothelin-1 in coronary vasculature. Am J Physiol Heart Circ Physiol. 2005;288:H2088-H2092. doi: 10.1152/ajpheart.00522.2003.
27. Chilian WM, Layne SM, Klausner EC, Eastham CL, Marcus ML. Redistribution of coronary microvascular resistance produced by dipyridamole. Am J Physiol. 1989;256:H383-H390.
28. Kuo L, Davis MJ, Chilian WM. Longitudinal gradients for endotheliumdependent and-independent vascular responses in the coronary microcirculation. Circulation. 1995;92:518-525.
29. Kanatsuka H, Lamping KG, Eastham CL, Dellsperger KC, Marcus ML. Comparison of the effects of increased myocardial oxygen consumption and adenosine on the coronary microvascular resistance. Circ Res. 1989;65:1296-1305.
30. Marcus ML, Chilian WM, Kanatsuka H, Dellsperger KC, Eastham CL, Lamping KG. Understanding the coronary circulation through studies at the microvascular level. Circulation. 1990;82:1-7.
31. Johnson BD, Shaw LJ, Buchthal SD, et al; National Institutes of Health-National Heart, Lung, and Blood Institute. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation. 2004;109:2993-2999. doi: 10.1161/01. CIR.0000130642.79868.B2.
32. Marroquin OC, Kip KE, Kelley DE, Johnson BD, Shaw LJ, Bairey Merz CN, Sharaf BL, Pepine CJ, Sopko G, Reis SE; Women's Ischemia Syndrome Evaluation Investigators. Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from the Women's Ischemia Syndrome Evaluation. Circulation. 2004;109:714-721. doi: 10.1161/01. CIR.0000115517.26897.A7.
33. von Mering GO, Arant CB, Wessel TR, McGorray SP, Bairey Merz CN, Sharaf BL, Smith KM, Olson MB, Johnson BD, Sopko G, Handberg E, Pepine CJ, Kerensky RA; National Heart, Lung, and Blood Institute. Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation. 2004;109:722-725. doi: 10.1161/01. CIR.0000115525.92645.16.
34. Pepine CJ, Anderson RD, Sharaf BL, Reis SE, Smith KM, Handberg EM, Johnson BD, Sopko G, Bairey Merz CN. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study. J Am Coll Cardiol. 2010;55:2825-2832. doi: 10.1016/j.jacc.2010.01.054.
35. Armstrong PW, Fu Y, Chang WC, Topol EJ, Granger CB, Betriu A, Van de Werf F, Lee KL, Califf RM. Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia. The GUSTOIIb Investigators. Circulation. 1998;98:1860-1868.
36. Murthy VL, Naya M, Foster CR, Gaber M, Hainer J, Klein J, Dorbala S, Blankstein R, Di Carli MF. Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus. Circulation. 2012;126:1858-1868. doi: 10.1161/CIRCULATIONAHA.112.120402.
37. Modell SM, Lehmann MH. The long QT syndrome family of cardiac ion channelopathies: a HuGE review. Genet Med. 2006;8:143-155. doi: 10.109701.gim.0000204468.85308.86.
38. Fedele F, Mancone M, Chilian WM, Severino P, Canali E, Logan S, De Marchis ML, Volterrani M, Palmirotta R, Guadagni F. Role of genetic polymorphisms of ion channels in the pathophysiology of coronary microvascular dysfunction and ischemic heart disease. Basic Res Cardiol. 2013;108:387. doi: 10.1007/s00395-013-0387-4.
39. Petersen JW, Pepine CJ. Microvascular coronary dysfunction and ischemic heart disease: where are we in 2014 Trends Cardiovasc Med. 2015;25:98-103. doi: 10.1016/j.tcm.2014.09.013.
40. Berne RM. The role of adenosine in the regulation of coronary blood flow. Circ Res. 1980;47:807-813.
41. Berne RM, Rubio R, Dobson JG Jr, Curnish RR. Adenosine and adenine nucleotides as possible mediators of cardiac and skeletal muscle blood flow regulation. Circ Res. 1971;28:Suppl 1:115+.
42. Stepp DW, Van Bibber R, Kroll K, Feigl EO. Quantitative relation between interstitial adenosine concentration and coronary blood flow. Circ Res. 1996;79:601-610.
43. Tune JD, Richmond KN, Gorman MW, Feigl EO. K(ATP)(+) channels, nitric oxide, and adenosine are not required for local metabolic coronary vasodilation. Am J Physiol Heart Circ Physiol. 2001;280:H868-H875.
44. Ishibashi Y, Duncker DJ, Zhang J, Bache RJ. ATP-sensitive K+ channels, adenosine, and nitric oxide-mediated mechanisms account for coronary vasodilation during exercise. Circ Res. 1998;82:346-359.
45. Duncker DJ, Van Zon NS, Altman JD, Pavek TJ, Bache RJ. Role of K+ATP channels in coronary vasodilation during exercise. Circulation. 1993;88:1245-1253.
46. Merkus D, Sorop O, Houweling B, Hoogteijling BA, Duncker DJ. K+Cachannels contribute to exercise-induced coronary vasodilation in swine. Am J Physiol Heart Circ Physiol. 2006;291:H2090-H2097. doi: 10.1152/ajpheart.00315.2006.
47. Richmond KN, Tune JD, Gorman MW, Feigl EO. Role of K+ATP channels in local metabolic coronary vasodilation. Am J Physiol. 1999;277:H2115-H2123.
48. Stepp DW, Kroll K, Feigl EO. K+ATP channels and adenosine are not necessary for coronary autoregulation. Am J Physiol. 1997;273:H1299-H1308.
49. Farias M III, Gorman MW, Savage MV, Feigl EO. Plasma ATP during exercise: possible role in regulation of coronary blood flow. Am J Physiol Heart Circ Physiol. 2005;288:H1586-H1590. doi: 10.1152/ajpheart.00983.2004.
50. Gorman MW, Rooke GA, Savage MV, Jayasekara MP, Jacobson KA, Feigl EO. Adenine nucleotide control of coronary blood flow during exercise. Am J Physiol Heart Circ Physiol. 2010;299:H1981-H1989. doi: 10.1152/ajpheart.00611.2010.
51. Berwick ZC, Dick GM, Moberly SP, Kohr MC, Sturek M, Tune JD. Contribution of voltage-dependent K+ channels to metabolic control of coronary blood flow. J Mol Cell Cardiol. 2012;52:912-919. doi: 10.1016/j. yjmcc.2011.07.004.
52. MacDonald PE, Ha XF, Wang J, Smukler SR, Sun AM, Gaisano HY, Salapatek AM, Backx PH, Wheeler MB. Members of the Kv1 and Kv2 voltage-dependent K(+) channel families regulate insulin secretion. Mol Endocrinol. 2001;15:1423-1435. doi: 10.1210/mend.15.8.0685.
53. Grissmer S, Nguyen AN, Aiyar J, Hanson DC, Mather RJ, Gutman GA, Karmilowicz MJ, Auperin DD, Chandy KG. Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines. Mol Pharmacol. 1994;45:1227-1234.
54. Mironova GD, Negoda AE, Marinov BS, Paucek P, Costa AD, Grigoriev SM, Skarga YY, Garlid KD. Functional distinctions between the mitochondrial ATP-dependent K+ channel (mitoKATP) and its inward rectifier subunit (mitoKIR). J Biol Chem. 2004;279:32562-32568. doi: 10.1074/jbc.M401115200.
55. Jabrek M, Yarov-Yarovoy V, Paucek P, Garlid KD. State-dependent inhibition of the mitochondrial KATP channel by glyburide and 5-hydroxydecanoate. J Biol Chem. 1998;273:13578-13582.
56. Szewczyk A, Czyz A, Naecz MJ. ATP-regulated potassium channel blocker, glibenclamide, uncouples mitochondria. Pol J Pharmacol. 1997;49:49-52.
57. Yao X, Chang AY, Boulpaep EL, Segal AS, Desir GV. Molecular cloning of a glibenclamide-sensitive, voltage-gated potassium channel expressed in rabbit kidney. J Clin Invest. 1996;97:2525-2533. doi: 10.1172/JCI118700.
58. Duprat F, Guillemare E, Romey G, Fink M, Lesage F, Lazdunski M, Honore E. Susceptibility of cloned K+ channels to reactive oxygen species. Proc Natl Acad Sci USA. 1995;92:11796-11800.
59. Conforti L, Bodi I, Nisbet JW, Millhorn DE. O2-sensitive K+ channels: role of the Kv1.2-subunit in mediating the hypoxic response. J Physiol. 2000;524(pt 3):783-793.
60. Zhang DX, Borbouse L, Gebremedhin D, Mendoza SA, Zinkevich NS, Li R, Gutterman DD. H2O2-induced dilation in human coronary arterioles: role of protein kinase G dimerization and large-conductance Ca2+-activated K+ channel activation. Circ Res. 2012;110:471-480. doi: 10.1161/CIRCRESAHA.111.258871.
61. Standen NB, Quayle JM. K+ channel modulation in arterial smooth muscle. Acta Physiol Scand. 1998;164:549-557. doi: 10.1046/j.1365-201X.1998.00433.x.
62. Honor E, Barhanin J, Attali B, Lesage F, Lazdunski M. External blockade of the major cardiac delayed-rectifier K+ channel (Kv1.5) by polyunsaturated fatty acids. Proc Natl Acad Sci USA. 1994;91:1937-1941.
63. Yang T, Wathen MS, Felipe A, Tamkun MM, Snyders DJ, Roden DM. K+ currents and K+ channel mRNA in cultured atrial cardiac myocytes (AT-1 cells). Circ Res. 1994;75:870-878.
64. Sadanaga T, Ohya Y, Ohtsubo T, Goto K, Fujii K, Abe I. Decreased 4-aminopyridine sensitive K+ currents in endothelial cells from hypertensive rats. Hypertens Res. 2002;25:589-596.
65. Chen WL, Huang XQ, Zhao LY, Li J, Chen JW, Xiao Y, Huang YY, Liu J, Wang GL, Guan YY. Involvement of Kv1.5 protein in oxidative vascular endothelial cell injury. PLoS One. 2012;7:e49758. doi: 10.1371/journal. pone.0049758.
66. Mi H, Deerinck TJ, Ellisman MH, Schwarz TL. Differential distribution of closely related potassium channels in rat Schwann cells. J Neurosci. 1995;15:3761-3774.
67. Vandenberg BF, Kieso R, Fox-Eastham K, Chilian W, Kerber RE. Quantitation of myocardial perfusion by contrast echocardiography: analysis of contrast gray level appearance variables and intracyclic variability. J Am Coll Cardiol. 1989;13:200-206.
68. Davidson BP, Chadderdon SM, Belcik JT, Gupta S, Lindner JR. Ischemic memory imaging in nonhuman primates with echocardiographic molecular imaging of selectin expression. J Am Soc Echocardiogr. 2014;27:786-793.e2. doi: 10.1016/j.echo.2014.03.013.
69. Kaufmann BA, Lankford M, Behm CZ, French BA, Klibanov AL, Xu Y, Lindner JR. High-resolution myocardial perfusion imaging in mice with high-frequency echocardiographic detection of a depot contrast agent. J Am Soc Echocardiogr. 2007;20:136-143. doi: 10.1016/j. echo.2006.08.008.
70. Lepper W, Belcik T, Wei K, Lindner JR, Sklenar J, Kaul S. Myocardial contrast echocardiography. Circulation. 2004;109:3132-3135. doi: 10.1161/01.CIR.0000132613.53542.E9.
71. Kaufmann BA, Wei K, Lindner JR. Contrast echocardiography. Curr Probl Cardiol. 2007;32:51-96. doi: 10.1016/j.cpcardiol.2006.10.004.
72. Gurudevan SV, Nelson MD, Rader F, Tang X, Lewis J, Johannes J, Belcik JT, Elashoff RM, Lindner JR, Victor RG. Cocaine-induced vasoconstriction in the human coronary microcirculation: new evidence from myocardial contrast echocardiography. Circulation. 2013;128:598-604. doi: 10.1161/CIRCULATIONAHA.113.002937.
73. Bratkovsky S, Aasum E, Birkeland CH, Riemersma RA, Myhre ES, Larsen TS. Measurement of coronary flow reserve in isolated hearts from mice. Acta Physiol Scand. 2004;181:167-172. doi: 10.1111/j.1365-201X.2004.01280.x.
74. Reichelt ME, Willems L, Hack BA, Peart JN, Headrick JP. Cardiac and coronary function in the Langendorff-perfused mouse heart model. Exp Physiol. 2009;94:54-70. doi: 10.1113/expphysiol.2008.043554.
75. Zhou X, Teng B, Tilley S, Ledent C, Mustafa SJ. Metabolic hyperemia requires ATP-sensitive K+ channels and H2O2 but not adenosine in isolated mouse hearts. Am J Physiol Heart Circ Physiol. 2014;307:H1046-H1055. doi: 10.1152/ajpheart.00421.2014.
76. Zhou Z, Rajamani U, Labazi H, Tilley SL, Ledent C, Teng B, Mustafa SJ. Involvement of NADPH oxidase in A2A adenosine receptor-mediated increase in coronary flow in isolated mouse hearts. Purinergic Signal. 2015;11:263-273. doi: 10.1007/s11302-015-9451-x.
77. Raher MJ, Thibault H, Poh KK, Liu R, Halpern EF, Derumeaux G, Ichinose F, Zapol WM, Bloch KD, Picard MH, Scherrer-Crosbie M. In vivo characterization of murine myocardial perfusion with myocardial contrast echocardiography: validation and application in nitric oxide synthase 3 deficient mice. Circulation. 2007;116:1250-1257. doi: 10.1161/CIRCULATIONAHA.107.707737.
78. van Nierop BJ, Coolen BF, Bax NA, Dijk WJ, van Deel ED, Duncker DJ, Nicolay K, Strijkers GJ. Myocardial perfusion MRI shows impaired perfusion of the mouse hypertrophic left ventricle. Int J Cardiovasc Imaging. 2014;30:619-628. doi: 10.1007/s10554-014-0369-0.